Topical Delgocitinib Rivals Dupilumab for Hand Eczema, but Adherence Is Key The American Journal of Managed Care Source link
Delgocitinib Cream Projected to Save US Health Plans Millions for Chronic Hand Eczema AJMC Source link
Delgocitinib Leads to Strong 16-Week Improvement in Chronic Hand Eczema The American Journal of Managed Care® (AJMC®) Source link
FDA Accepts sNDA for Delgocitinib Cream to Treat Pediatric Chronic Hand Eczema Dermatology Times Source link